Trial intelligence / Profile preview

Nefopam PK for Thermoregulation

NCT03122665Phase 1Completed

Sponsor
Cleveland Clinic
Start
Aug 2004
Primary completion
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of nefopam (2 arms), sponsored by Cleveland Clinic. Primary endpoints: Volume of distribution of the central compartment at 3 hours, Volume of distribution of the peripheral compartment at 3 hours and 2 more. Started Aug 2004; status: completed.

02

Drugs

nefopam

Beyond the preview

Go deeper on NCT03122665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03122665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call